SUBSCRIBE
SUBSCRIBE
News   Business

Ariad Pharmaceuticals, Inc. to Receive $2.5 Million from Partner Merck & Co., Inc.

August 6, 2008 | 
1 min read
CAMBRIDGE, Mass. (AP) -- Ariad Pharmaceuticals Inc. said Wednesday it will receive a $2.5 million payment from partner Merck & Co. for moving a cancer drug into midstage clinical trials.
Alliances
Merck & Co.
MORE ON THIS TOPIC
Illustration of a group of businessmen white-collar workers dismissed
Layoffs
Pliant Axes 45% of Workforce To Save Cash, Support Late-Stage Clinical Trials
May 2, 2025
 · 
2 min read
 · 
Angela Gabriel
Hand scales with pile of money and bottles of drugs and pills. Health insurance and healthcare. Buying and selling drugs. Pharmacy shop. Vector illustration in flat style
Drug pricing
Low-Price Drug Nations Catching ‘Free Ride’ on US Innovation, Report Says
May 2, 2025
 · 
3 min read
 · 
Annalee Armstrong
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Pictured: Amgen's office in Massachusetts/iStock,
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
May 2, 2025
 · 
2 min read
 · 
Tristan Manalac